Saturday, June 19, 2010

Published Journal - The Lancet (Best Award Ever)

Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study

Summary

Background

The contribution of various risk factors to the burden of stroke worldwide is unknown, particularly in countries of low and middle income. We aimed to establish the association of known and emerging risk factors with stroke and its primary subtypes, assess the contribution of these risk factors to the burden of stroke, and explore the differences between risk factors for stroke and myocardial infarction.

Methods

We undertook a standardised case-control study in 22 countries worldwide between March 1, 2007, and April 23, 2010. Cases were patients with acute first stroke (within 5 days of symptoms onset and 72 h of hospital admission). Controls had no history of stroke, and were matched with cases for age and sex. All participants completed a structured questionnaire and a physical examination, and most provided blood and urine samples. We calculated odds ratios (ORs) and population-attributable risks (PARs) for the association of all stroke, ischaemic stroke, and intracerebral haemorrhagic stroke with selected risk factors.

Findings

In the first 3000 cases (n=2337, 78%, with ischaemic stroke; n=663, 22%, with intracerebral haemorrhagic stroke) and 3000 controls, significant risk factors for all stroke were: history of hypertension (OR 2·64, 99% CI 2·26—3·08; PAR 34·6%, 99% CI 30·4—39·1); current smoking (2·09, 1·75—2·51; 18·9%, 15·3—23·1); waist-to-hip ratio (1·65, 1·36—1·99 for highest vsvs lowest tertile; 18·8%, 11·2—29·7); regular physical activity (0·69, 0·53—0·90; 28·5%, 14·5—48·5); diabetes mellitus (1·36, 1·10—1·68; 5·0%, 2·6—9·5); alcohol intake (1·51, 1·18—1·92 for more than 30 drinks per month or binge drinking; 3·8%, 0·9—14·4); psychosocial stress (1·30, 1·06—1·60; 4·6%, 2·1—9·6) and depression (1·35, 1·10—1·66; 5·2%, 2·7—9·8); cardiac causes (2·38, 1·77—3·20; 6·7%, 4·8—9·1); and ratio of apolipoproteins B to A1 (1·89, 1·49—2·40 for highest vs lowest tertile; 24·9%, 15·7—37·1). Collectively, these risk factors accounted for 88·1% (99% CI 82·3—92·2) of the PAR for all stroke. When an alternate definition of hypertension was used (history of hypertension or blood pressure >160/90 mm Hg), the combined PAR was 90·3% (85·3—93·7) for all stroke. These risk factors were all significant for ischaemic stroke, whereas hypertension, smoking, waist-to-hip ratio, diet, and alcohol intake were significant risk factors for intracerebral haemorrhagic stroke. lowest tertile; 26·5%, 18·8—36·0); diet risk score (1·35, 1·11—1·64 for highest

Interpretation

Our findings suggest that ten risk factors are associated with 90% of the risk of stroke. Targeted interventions that reduce blood pressure and smoking, and promote physical activity and a healthy diet, could substantially reduce the burden of stroke.

Funding

Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, Canadian Stroke Network, Pfizer Cardiovascular Award, Merck, AstraZeneca, and Boehringer Ingelheim.

 INTERSTROKE national coordinators, investigators, and key staff Argentina R Diaz*, L Sposato, C Bahit, M Bianchi, A Pascual, M E Martin, P Schygiel, G Falcone, M Garrote. Australia J Varigos*, G Hankey*,
A Claxton, W Y Wang. Brazil A Avezum*, I Santos, M P Pereira, R Nakamura, K Takeuti, L Avezum, S Faria, M Teixeira, A Gaff ga, H Reis, A Lameira, M Friedrich, L C Marrone, J F K Saraiva, A C Carvalho,
I Rocha, V L Laet, M Coutinho, F Brunel, L Melges, C R Garbelini, A C Baruzzi, D A Reis. Canada M O’Donnell*, S Yusuf*, S Ounpuu, M K Kapral, J DeJesus, D Gladstone, G Valencia, P Teal, A Woolfendan, P Masigan, K Murray, J Sancan, A Shuaib, B Schwindt, F Silver, M Sharma, M Mortensen. Chile F Lanas*, S Saavera. China L Liu*, H Zhang, X Wang, W Wang, J Li, L Liu, Y Sun, J Chen, L Zhou, W Jia, Z Zhang, J Lv, C Zhang, G Chen, H Wang, L Liu, Y Zhang, Y Chen, H Zheng, Y Zhang, J Wang, J Huang, Z Deng, W Zhang, W Li, S Jia, J Wang, L Wang, J Wang, J Shi, W Gu, H Shao, Y Hu, H Song, R Ji, L Hao, J Zhang, F Hou, D Wang, J Li, L Meng, L Duan. Colombia P L Jaramillo*, G Sanchez, R Garcia, J Arguello, N Ruiz, D I Molina, A Sotomayor, K Sotomayor, M Suarez. Croatia Z Rumboldt*, I Lusic. Denmark T Truelsen*, H K Iversen, C Back, M M Petersen. Ecuador E Panaherrera*, Y C Duarte, S Caceres. Germany C Weimar*, A J Grau, B Bode, J Roether, H Wuttig, K Busch. India P Pais*, D Xavier*, A Sigamani, N P Mathur, P Rahul, D Rai, A K Roy, G R K Sarma, T Mathew, G Kusumkar, K A Salam, U Karadan, L Achambat, Y Singh, J D Pandian, R Verma, V Atam, A Agarwal, N Chidambaran, R Umarani, S Ghanta, G K Babu, G Sathyanarayana, G Sarada, S Navya Vani, R Sundararajan, S S Sivakumar, R S Wadia, S Bandishti, R Gupta, R R Agarwal, I Mohan, S Joshi, S Kulkarni, S Parthasaradhi, P Joshi, M Pandharipande, N Badnerkar, R Joshi, S P Kalantri, S Somkuwar, S Chavhan, H Singh, S Varma, H Singh, G K Sidhu, R Singh, K L Bansal, A Bharani, S Pagare, A Chouhan, B N Mahanta, T G Mahanta, G Rajkonwar, S K Diwan, S N Mahajan, P Shaikh. Iran S Oveisgharan*, R Kelishadi, A Bahonar, N Mohammadifard, H Heidari, A Dehghani, SA Mousavi. Kuwait O Albaker*.
Malaysia K Yusoff *, A Chandramouli, N Syuhadamohd. Mozambique A Damasceno*, S Loureiro. Nigeria O S Ogah*. A Ogunniyi*, R Akinyemi, M Owolabi, A Oguunniyi, I O Onwuekwe, S Mahmoud, L Owolabi. Peru G Malaga*, Z Salazar, P Ponce de Leaon, E Najar, M Aphang. Philippines A L Dans*, M V Sulit, E Collantes, M del Castillo, D Morales, C Lagayan, M Candela, A Roxas, I Tan, C Recto, G Lau. Poland A Czlonkowska*, D Ryglewicz*, M Skowronska, M Restel, A Bochynska, K Chwojnicki, M Kubach, A Stowik, M Wnuk. South Africa L DeVilliers*, B Mayosi, D Magazi. Sudan A S A Elsayed*, A Bukhari, Z Sawaraldahab, H Hamad, M ElTaher, A Abdelhameed, M Alawad, D Alkabashi, H Alsir. Sweden A Rosengren*, M Andreasson, B Cederin, C Schander, A C Elgasen, E Bertholds, K Bengtasson. Thailand Y Nilanont*, N Samart*, T Pyatat, N Prayoonwiwat, N Phongwarin, N C Suwanwela, S Tiamkao, R Tulyapronchote, S Boonyakarnkul, S Hanchaiphiboolkul, S Muengtaweepongsa, K Watcharasakslip, P Sathirapanya, P Pleumpanupat. Turkey A Oguz*, A A K Akalin. Uganda C Mondo*, J Kayima, M Nakisige, S Kitoleeko, P Byanyima. UK P Langhorne*. USA R Sacco, L Hilbrich. *National coordinator.

* Adapted from The Lancet, Volume 376, Issue 9735, Pages 112 - 123, 10 July 2010
Published Online: 18 June 2010

Even a 1000 cups of coffee with a friend it is too little (n_n)v

Monday, May 17, 2010

The CenTRE: Centre for Translational Research and Epidemiology

 
Important: Adequate staff and facilities leads to successful Clinical Trial Centre...Much appreciated for our Deans, Professor of Cardiology and also experienced in Clinical Trial for almost 11 years.The CenTRE (^__^)
ni bilik sumber ilham...

Ruang menunggu..penting untuk pesakit supaya selesa...

Ruang sembang untuk pesakit...
Kerusi empuk...best untuk tido


Bilik rawatan...



Bilik perundingan...kaunseling is a part of it

Bilik pengambilan sampel....


Triage...


Lab yang maha besar dan luas mata memandang..

Mana nak carik muker bahagia canni..

This is wat we call, investigators files...
CenTRE's Staff
Frenz who owez encourage =)
Bab makan2,memang slalu jer ada...





Many thanks to Faculty of Medicine Dean.

Even a 1000 cups of coffee with a friend it is too little (n_n)v

Wednesday, November 18, 2009

INTERSTROKE Investigators Meeting, Beijing China

Salam Perantau

Its freezing during the nite!






Ditaja Oleh: Boss

Ditaja Oleh: Boss






Nice Food from Emperor's Restaurant

Forbidden City

The West Holy Gate
 

Winter...



 



Delicious!
 
Birdnest Stadium


Greatwall...I manage to get to 1st Tower only...

Christmas Eve Celebrated @ One World Hotel

Never End Lover
Nice View

Keep us warm!

Jalan2 makan angin kat taman.Freezing!

Waiting for another tourist

One World Hotel..its RM1000 per nite...
Kan bagus kalau boss bagi duit poket utk shopping! Ahakz

Dinner with Dr. Ng Kien Keat and others

Pi jalan2 ke Pearl Market using the train. Awesome!


Even a 1000 cups of coffee with a friend it is too little (n_n)v

Saturday, November 14, 2009

Good Clinical Practice

Passed GCP with fying colours~~~ The most important requirement for any investigators to be involved in clinical trial. Noe why? Because Good Clinical Practice (GCP) is a standard for the design, conduct, performance, monitoring, auditing, recording, analysis and reporting of clinical trials that provides assurance that the data and reported results are credible and accurate, and that the rights, integrity and confidentiality of trial subjects are protected!

My suggestion: Better practice wat u learn..dun dump it!


Add caption


Venue: INTEKMA, Shah Alam
 Secretariat: Faculty of Medicine

 Participant: Those who interested in Clinical Trial
 Tips: Immediate digest
 The exam will be on the 3rd Day of GCP Course.

Can practice GCP by now =)
Even a 1000 cups of coffee with a friend it is too little (n_n)v